Source: ERJ Open Res, 6 (4) 00044-2020; 10.1183/23120541.00044-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Jørgen Vestbo, Christer Janson, Javier Nuevo, David Price. Observational studies assessing the pharmacological treatment of obstructive lung disease: strengths, challenges and considerations for study design. ERJ Open Res, 6 (4) 00044-2020; 10.1183/23120541.00044-2020

Member's Comments

No comment yet.

Related content which might interest you: Methodological issues in therapeutic trials of COPD Source: Eur Respir J 2008; 31: 927-933 Year: 2008 How to increase the value of randomised trials in COPD research Source: Eur Respir J 2009; 34: 552 Year: 2009 A prospective study of asthma incidence and its predictors: the RHINE study Source: Eur Respir J 2004; 24: 942-946 Year: 2004 A non-interventional observational trial to study the COPD treatment choices in routine clinical practice in Bulgaria Source: International Congress 2016 – COPD diagnosis and management Year: 2016 REALizing and improving management of COPD in China: A prospective observational study Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 Effectiveness versus efficacy trials in COPD: how study design influences outcomes and applicability Source: Eur Respir J, 51 (2) 1701531; 10.1183/13993003.01531-2017 Year: 2018 The effect of anti-acid therapy on survival in idiopathic pulmonary fibrosis: a methodological review of observational studies Source: Eur Respir J, 51 (6) 1800376; 10.1183/13993003.00376-2018 Year: 2018 Epidemiological studies in idiopathic pulmonary fibrosis: pitfalls in methodologies and data interpretation Source: Eur Respir Rev 2015; 24: 436-444 Year: 2015 Technology-delivered psychosocial intervention in COPD: a feasibility study Source: International Congress 2017 – Latest insights into chronic care Year: 2017 The long-term clinical and economic impact of COPD exacerbations: an observational study (SHERLOCK) Source: Virtual Congress 2020 – Prediction and management of outcomes in obstructive diseases Year: 2020 Providing reviews of evidence to people with chronic disease: controlled prospective study in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 29s Year: 2006 Is poor asthma self-management due to failure to recognise symptoms or failure to act? Novel insights from mining large-scale clinical observational study Source: International Congress 2019 – M-health/e-health II Year: 2019 Do marker states improve measurement properties of utility instruments: a randomized multi-center trial in patients with chronic respiratory disease Source: Eur Respir J 2004; 24: Suppl. 48, 295s Year: 2004 Safety and benefits of beta-blockers in chronic obstructive pulmonary disease: a review of current evidence and meta-analysis Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018 Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies Source: Guideline 1997 Year: 1997 Recommendations for epidemiological studies on COPD Source: Eur Respir J 2011; 38: 1261-1277 Year: 2011 Prospective observational study in patients with obstructive lung disease: NOVELTY design Source: ERJ Open Res, 5 (1) 00036-2018; 10.1183/23120541.00036-2018 Year: 2019 Challenges in classification of asthma severity from prescription data: a pilot study Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 An Italian, observational, multicentre trial to describe treatment management in COPD patients: Preliminary results of the MISTRAL study Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Effects of a comprehensive pulmonary rehabilitation (PR)-program on frailty in lung transplantation candidates – a prospective observational study Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation Year: 2020